A detailed history of Worth Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Worth Asset Management, LLC holds 40,511 shares of BMY stock, worth $2.33 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
40,511
Holding current value
$2.33 Million
% of portfolio
1.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$39.66 - $51.75 $1.61 Million - $2.1 Million
40,511 New
40,511 $2.1 Million
Q4 2022

Jan 12, 2023

SELL
$68.48 - $81.09 $5,136 - $6,081
-75 Reduced 14.88%
429 $0
Q3 2022

Oct 07, 2022

SELL
$0.13 - $76.84 $2,235 - $1.32 Million
-17,197 Reduced 97.15%
504 $35,000
Q2 2022

Jul 08, 2022

SELL
$72.62 - $79.98 $388,153 - $427,493
-5,345 Reduced 23.19%
17,701 $1.36 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $1.42 Million - $1.7 Million
23,046 New
23,046 $1.76 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Worth Asset Management, LLC Portfolio

Follow Worth Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Asset Management, LLC with notifications on news.